BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19750004)

  • 1. A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia.
    Plaisier CL; Horvath S; Huertas-Vazquez A; Cruz-Bautista I; Herrera MF; Tusie-Luna T; Aguilar-Salinas C; Pajukanta P
    PLoS Genet; 2009 Sep; 5(9):e1000642. PubMed ID: 19750004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1.
    Huertas-Vazquez A; Aguilar-Salinas C; Lusis AJ; Cantor RM; Canizales-Quinteros S; Lee JC; Mariana-Nuñez L; Riba-Ramirez RM; Jokiaho A; Tusie-Luna T; Pajukanta P
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1985-91. PubMed ID: 15976322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USF1 contributes to high serum lipid levels in Dutch FCHL families and U.S. whites with coronary artery disease.
    Lee JC; Weissglas-Volkov D; Kyttälä M; Sinsheimer JS; Jokiaho A; de Bruin TW; Lusis AJ; Brennan ML; van Greevenbroek MM; van der Kallen CJ; Hazen SL; Pajukanta P
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2222-7. PubMed ID: 17673701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation within the gene encoding the upstream stimulatory factor 1 does not influence susceptibility to type 2 diabetes in samples from populations with replicated evidence of linkage to chromosome 1q.
    Zeggini E; Damcott CM; Hanson RL; Karim MA; Rayner NW; Groves CJ; Baier LJ; Hale TC; Hattersley AT; Hitman GA; Hunt SE; Knowler WC; Mitchell BD; Ng MC; O'Connell JR; Pollin TI; Vaxillaire M; Walker M; Wang X; Whittaker P; Xiang K; Jia W; Chan JC; Froguel P; Deloukas P; Shuldiner AR; Elbein SC; McCarthy MI;
    Diabetes; 2006 Sep; 55(9):2541-8. PubMed ID: 16936202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).
    Pajukanta P; Lilja HE; Sinsheimer JS; Cantor RM; Lusis AJ; Gentile M; Duan XJ; Soro-Paavonen A; Naukkarinen J; Saarela J; Laakso M; Ehnholm C; Taskinen MR; Peltonen L
    Nat Genet; 2004 Apr; 36(4):371-6. PubMed ID: 14991056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides.
    Coon H; Xin Y; Hopkins PN; Cawthon RM; Hasstedt SJ; Hunt SC
    Hum Genet; 2005 Sep; 117(5):444-51. PubMed ID: 15959806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the complex genetics of familial combined hyperlipidemia.
    Suviolahti E; Lilja HE; Pajukanta P
    Ann Med; 2006; 38(5):337-51. PubMed ID: 16938803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population.
    Di Taranto MD; Staiano A; D'Agostino MN; D'Angelo A; Bloise E; Morgante A; Marotta G; Gentile M; Rubba P; Fortunato G
    Mol Cell Probes; 2015 Feb; 29(1):19-24. PubMed ID: 25308402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of chromosome 1q21-q23 to familial combined hyperlipidemia in Mexican families.
    Huertas-Vázquez A; del Rincón JP; Canizales-Quinteros S; Riba L; Vega-Hernández G; Ramírez-Jiménez S; Aurón-Gómez M; Gómez-Pérez FJ; Aguilar-Salinas CA; Tusié-Luna MT
    Ann Hum Genet; 2004 Sep; 68(Pt 5):419-27. PubMed ID: 15469419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of upstream stimulatory factor 1 gene variant in familial combined hyperlipidemia and related disorders.
    Auer S; Hahne P; Soyal SM; Felder T; Miller K; Paulmichl M; Krempler F; Oberkofler H; Patsch W
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1535-44. PubMed ID: 22460558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of familial combined hyperlipidemia.
    Naukkarinen J; Ehnholm C; Peltonen L
    Curr Opin Lipidol; 2006 Jun; 17(3):285-90. PubMed ID: 16680034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USF1 gene variants, cardiovascular risk, and mortality in European Americans: analysis of two US cohort studies.
    Reiner AP; Carlson CS; Jenny NS; Durda JP; Siscovick DS; Nickerson DA; Tracy RP
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2736-42. PubMed ID: 17885212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation in USF1 gene is associated with familial combined hyperlipidemia.
    Taghizadeh E; Mirzaei F; Jalilian N; Ghayour Mobarhan M; Ferns GA; Pasdar A
    IUBMB Life; 2020 Apr; 72(4):616-623. PubMed ID: 31725952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetics of familial combined hyperlipidaemia.
    Brouwers MC; van Greevenbroek MM; Stehouwer CD; de Graaf J; Stalenhoef AF
    Nat Rev Endocrinol; 2012 Feb; 8(6):352-62. PubMed ID: 22330738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upstream transcription factor 1 influences plasma lipid and metabolic traits in mice.
    Wu S; Mar-Heyming R; Dugum EZ; Kolaitis NA; Qi H; Pajukanta P; Castellani LW; Lusis AJ; Drake TA
    Hum Mol Genet; 2010 Feb; 19(4):597-608. PubMed ID: 19995791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCF7L2 is associated with high serum triacylglycerol and differentially expressed in adipose tissue in families with familial combined hyperlipidaemia.
    Huertas-Vazquez A; Plaisier C; Weissglas-Volkov D; Sinsheimer J; Canizales-Quinteros S; Cruz-Bautista I; Nikkola E; Herrera-Hernandez M; Davila-Cervantes A; Tusie-Luna T; Taskinen MR; Aguilar-Salinas C; Pajukanta P
    Diabetologia; 2008 Jan; 51(1):62-9. PubMed ID: 17972059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemia.
    Nanni L; Quagliarini F; Megiorni F; Montali A; Minicocci I; Campagna F; Pizzuti A; Arca M
    Atherosclerosis; 2010 Nov; 213(1):206-11. PubMed ID: 20832801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomewide scan for familial combined hyperlipidemia genes in finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels.
    Pajukanta P; Terwilliger JD; Perola M; Hiekkalinna T; Nuotio I; Ellonen P; Parkkonen M; Hartiala J; Ylitalo K; Pihlajamäki J; Porkka K; Laakso M; Viikari J; Ehnholm C; Taskinen MR; Peltonen L
    Am J Hum Genet; 1999 May; 64(5):1453-63. PubMed ID: 10205279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linkage of a candidate gene locus to familial combined hyperlipidemia: lecithin:cholesterol acyltransferase on 16q.
    Aouizerat BE; Allayee H; Cantor RM; Dallinga-Thie GM; Lanning CD; de Bruin TW; Lusis AJ; Rotter JI
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2730-6. PubMed ID: 10559018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia.
    Eurlings PM; van der Kallen CJ; Vermeulen VM; de Bruin TW
    Mol Genet Metab; 2003 Nov; 80(3):296-301. PubMed ID: 14680975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.